Package Leaflet: Information for the Patient
Calthek500 mg Tablets
Readthe entire package leaflet carefully before starting to take this medication,as it contains important information for you.
Contentsof the Package Leaflet
5 Conservation of Calthek
Paracetamol is effective in reducing pain and fever.
It is indicated for the symptomatic relief of occasional pain of mild to moderate intensity and febrile states in adults and children over 10 years old (body weight over 33 kg).
Do not takeCalthek
Paracetamol should be used with special caution in the following situations:
Do not take more medication than recommended in section 3.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Paracetamol.
If the pain persists for more than 5 days, the fever for more than 3 days, or the pain or fever worsens or other symptoms appear, the clinical situation should be evaluated by your doctor. This medication should not be used for self-medication of high fever (over 39°C), fever that lasts more than 3 days, or recurrent fever, unless indicated by your doctor, as these situations may require medical evaluation and treatment.
The administration of paracetamol doses higher than recommended implies a very serious risk of liver injury. Medications that contain paracetamol should not be taken for more than a few days or in high doses unless indicated by your doctor.
Prolonged use of analgesics or inadequate use of high doses can cause headaches, which should not be treated with higher doses of the medication.
During treatment with Calthek, inform your doctor immediately if:
If you have serious illnesses, such as severe renal insufficiency or sepsis (when bacteria and their toxins circulate in the blood, causing organ damage), or if you have malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A serious disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling of discomfort (nausea) and vomiting.
Other medications andCalthek
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
In particular, if you are using any of the following medications, it may be necessary to modify the dose of one of them or interrupt treatment:
Inform your doctor or pharmacist if you are taking:
Flucloxacillin (antibiotic), due to a serious risk of blood and fluid anomalies (metabolic acidosis with high anion imbalance) that should be treated urgently.
Interference with analytical tests:
If you are going to have any analytical tests (including blood, urine, etc.), inform your doctor that you are taking this medication, as it may alter the results. Paracetamol may alter the values of analytical determinations of uric acid and glucose.
TakingCalthekwith food, drinks, and alcohol
The use of paracetamol in patients who habitually consume alcohol (3 or more alcoholic beverages: beer, wine, liquor, ... per day) may cause liver damage.
Taking this medication with food does not affect its efficacy.
Children and adolescents
Paracetamol should not be used in children under 10 years of age or weighing less than 33 kg.
Pregnancy, breastfeeding, and fertility
Consult your doctor or pharmacist before taking this medication
IMPORTANT FOR WOMENIf you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. Taking medications during pregnancy can be dangerous for the embryo or fetus and should be controlled by your doctor.
Pregnancy and breastfeeding
If necessary, Paracetamol can be used during pregnancy. You should use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor if the pain or fever does not decrease or if you need to take the medication more frequently.
Breastfeeding
Consult your doctor or pharmacist before taking this medication.
Paracetamol passes into breast milk, so breastfeeding women should consult their doctor or pharmacist before taking this medication.
Fertility
No harmful effects on fertility are known with the normal use of paracetamol
Driving and using machines:
The influence of paracetamol on the ability to drive and use machines is nil or insignificant.
Follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist.
The recommended dose is:
Adults andadolescents over 15 years old (body weight over 50 kg):
1 tablet every 4-6 hours.
The doses should be spaced at least 4 hours apart.
Maximum dosage: Do not exceed 3 g of paracetamol (6 tablets) in 24 hours.
Children and adolescents over 10 years old (body weight over 33 kg)
It is necessary to respect the dosages defined according to weight. The child's age is given for informational purposes.
-Children between 33 kg and 40 kg in weight: 1 tablet 3 or 4 times a day. The doses should be spaced at least 4 hours apart.
Maximum dosage: 4 tablets per day.
-Between 41 and 50 kg in weight: 1 tablet 3 or 4 times a day. The doses should be spaced at least 4 hours apart.
Maximum dosage: 5 tablets per day.
Paracetamol should not be used in children under 10 years of age or weighing less than 33 kg.
Patient with liver disease: consult your doctor before taking this medication.
They should take the prescribed amount of medication with a minimum interval of 8 hours between each dose.
They should not take more than 2 g (4 tablets) in 24 hours. The doses should be spaced at least 4 hours apart.
In chronic alcoholics, the dose should not exceed 2 g per day.
Patient with kidney disease: Consult your doctor before taking this medication.
Patients with moderate to severe renal disease should take a maximum of 500 mg of paracetamol per dose, every 6-8 hours.
This medication is taken orally.
The tablets should be swallowed with the help of a glass of liquid, preferably water.
The tablets are scored, which allows them to be divided in half. The tablet can be divided into equal doses.
Always use the lowest effective dose.
High daily doses of paracetamol should be avoided during prolonged periods, as the risk of adverse effects such as liver damage increases.
The administration of this medication is subject to the appearance of pain or fever. As they disappear, treatment should be discontinued.
If the pain persists for more than 5 days, the fever for more than 3 days, or the pain or fever worsens or other symptoms appear, treatment should be discontinued and your doctor consulted.
If you take moreCalthekthan you should
You should consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service (telephone 91 562 04 20), indicating the medication and the amount ingested.
If you have ingested an overdose, you should go quickly to a medical center even if you have no symptoms, as they often do not manifest until 3 days after ingestion of the overdose, even in cases of severe poisoning.
The symptoms of overdose may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), and abdominal pain.
Treatment of the overdose is more effective if started within 4 hours after ingestion of the medication.
Patient taking barbiturics or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
If you forget to takeCalthek
Do not take a double dose to make up for forgotten doses. If you forget to take a dose, take the forgotten dose as soon as you remember, taking the following doses with the indicated separation between doses (at least 4 hours).
If you stop treatment withCalthek
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can have side effects, although not everyone experiences them.
The following side effects have been reported:
Rare: may affect up to 1 in 1,000 people.
Very rare: may affect up to 1 in 10,000 people
Frequency not known (cannot be estimated from available data):
A serious disease that can make the blood more acidic (called metabolic acidosis) in patients with serious disease using paracetamol (see section 2).
Paracetamol may damage the liver when taken in high doses or in prolonged treatments.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition ofCalthek
Appearance of the product and contents of the packaging
The tablets are oblong, biconvex, white, and scored, approximately 18 mm long and 8 mm wide.
Calthek is presented in packages of 20 tablets packaged in PVC/PVDC-Aluminum blisters.
Marketing authorization holder
Apotheke Laboratorios, S.L.
Paseo de la Castellana 40, 8th floor
28046 – Madrid, Spain
Manufacturer:
Toll Manufacturing Services, S.L.
c/ Aragoneses, 2
28108 Alcobendas (Madrid)
Spain
or
Pharmex Advanced Laboratories S.L.
Ctra. A-431 Km.
Almodóvar del Río, 19
14720 Córdoba
Spain
or
Farmalider, S.A.
C/ Aragoneses, 2
28108 Alcobendas (Madrid)
Spain
Date of the last revision of this package leaflet: March 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/